Congratulations! Further proof that good technology can attract venture funding, irrespective of geographic location.
iCardiac Technologies Completes Oversubscribed Series A Round
ROCHESTER, N.Y., Nov. 7-- iCardiac Technologies, Inc., a company formed earlier this year to commercialize leading cardiac safety technologies developed at the University of Rochester Medical Center, announced today that it has completed its Series A offering with an additional investment of $2 million. This investment, led by the national venture capital firms of Advantage Capital Partners and Stonehenge Capital Company, brings the total Series A investment to $4 million.
Comments